This inventor holds 1 USPTO granted patent. Top assignee: Gruenenthal Gmbh. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Ellen Klegraf: Pioneering Inventor at the Forefront of Pharmaceutical Innovation
Introduction: Ellen Klegraf, a visionary inventor hailing from Brig, Switzerland, is a trailblazer in the field of pharmaceutical innovation. With a relentless drive to make a difference, Klegraf's passion for innovation sets her apart as a forward-thinking inventor whose work continues to inspire and shape the future of technology.
Latest Patents: Ellen Klegraf holds one patent for "Substituted sulfonamide compounds" corresponding to formula I. These compounds are utilized in pharmaceutical compositions for treating conditions mediated by the bradykinin 1 receptor.
Career Highlights: With a keen focus on research and development, Ellen Klegraf has made significant contributions to the pharmaceutical industry. Her dedication to creating innovative solutions for treating pain and other related conditions highlights her as a leader in the field.
Collaborations: Klegraf collaborates closely with her coworkers at Gruenenthal GmbH, including Melanie Reich and Stefan Oberboersch. Together, they form a dynamic team driving advancements in pharmaceutical technology and paving the way for groundbreaking treatments.
Conclusion: Ellen Klegraf's unwavering commitment to innovation and her pioneering spirit make her a standout inventor in the realm of pharmaceuticals. Her impact on the industry continues to reverberate, laying the foundation for future advancements that will enhance medical treatments and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
